治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx

上传人:b****9 文档编号:26025083 上传时间:2023-06-17 格式:DOCX 页数:34 大小:40.69KB
下载 相关 举报
治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx_第1页
第1页 / 共34页
治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx_第2页
第2页 / 共34页
治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx_第3页
第3页 / 共34页
治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx_第4页
第4页 / 共34页
治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx_第5页
第5页 / 共34页
点击查看更多>>
下载资源
资源描述

治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx

《治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx》由会员分享,可在线阅读,更多相关《治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx(34页珍藏版)》请在冰豆网上搜索。

治疗色素沉着Approach to the patient with hyperpigmentation disorders.docx

治疗色素沉着Approachtothepatientwithhyperpigmentationdisorders

Approachtothepatientwithhyperpigmentationdisorders

Authors

NeelamVashi,MD

RoopalKundu,MD

SectionEditor

ErikStratman,MD

DeputyEditor

RosamariaCorona,MD,DSc

Disclosures:

NeelamVashi,MDConsultant/AdvisoryBoards:

L'Oreal[Hyperpigmentation].RoopalKundu,MDNothingtodisclose.ErikStratman,MDNothingtodisclose.RosamariaCorona,MD,DScNothingtodisclose.

Contributordisclosuresarereviewedforconflictsofinterestbytheeditorialgroup.Whenfound,theseareaddressedbyvettingthroughamulti-levelreviewprocess,andthroughrequirementsforreferencestobeprovidedtosupportthecontent.AppropriatelyreferencedcontentisrequiredofallauthorsandmustconformtoUpToDatestandardsofevidence.

Conflictofinterestpolicy

Alltopicsareupdatedasnewevidencebecomesavailableandourpeerreviewprocessiscomplete.

Literaturereviewcurrentthrough:

Jul2015.|Thistopiclastupdated:

Jan19,2015.

INTRODUCTION — Hyperpigmentationisthedarkeningorincreaseinthenaturalcoloroftheskinusuallyduetoanincreaseddepositionofmelanin(hypermelanosis)intheepidermisand/ordermis.Lessfrequently,itmaybecausedbythedepositioninthedermisofendogenousorexogenouspigments,suchashemosiderin,iron,orheavymetals.

Hyperpigmentationisafeatureofamultitudeofclinicalconditions,rangingfromnormalvariationsofskincolortoacquiredandinheritedsyndromes,andisoneofthemostcommonreasonsfordermatologicconsultation,particularlyinpatientswithdarkerskintypes[1-3].Althoughhyperpigmentationisnotharmful,itcancausesignificantcosmeticdisfigurementandbecomeapersistentpsychosocialburdenforthepatient,duetothelimitedefficacyoftheavailabletreatments.

Thistopicwillreviewtheapproachtothepatientwithhyperpigmentationdisorders.Melasmaisdiscussedseparately.Benignandmalignantmelanocytictumorsarediscussedseparately.

●(See"Melasma".)

●(See"Benignpigmentedskinlesionsotherthanmelanocyticnevi(moles)".)

●(See"Acquiredmelanocyticnevi(moles)".)

●(See"Skinexaminationandclinicalfeaturesofmelanoma".)

PATHOPHYSIOLOGY

Determinantsofskincolor — Thecolorofhumanskinismainlydeterminedbythetwotypesofmelanin,theblack-browneumelaninandtheyellow-redpheomelanin.Othersignificantdeterminantsarethecapillarybloodflow,chromophoressuchascaroteneorlycopene,andthecollagencontentofthedermis.

Eumelaninandpheomelaninarepresentinindividualofallskincolors,buttheirratioishighlyvariableanddeterminesthehueoftheskin[4].Differencesinthenumber,size,andaggregationofmelanosomeswithinthemelanocytesandkeratinocytes,butnotintheoverallnumberofmelanocytes,contributetoethnicdifferencesinskincolor[5,6].Darkerskintypeshaveahighercontentofmelanin,highereumelanin-to-pheomelaninratio,nonaggregatedandlargermelanosomes,andslowermelanosomedegradationwithinthekeratinocytes[7].

Melanin — Melaninisproducedbymelanocytes,specializedcellsofneuralcrestoriginthatresideinthebasallayeroftheepidermis.Thebiosynthesisofmelaninoccursinlysosome-likeorganellescalledmelanosomes,whicharetransportedtothecellperipheryandtransferredfromthedendritictipsofthemelanocytestothesurroundingkeratinocytes[8].Eachmelanocyteisassociatedwithapproximately36basalkeratinocytestoformtheso-calledepidermalmelaninunit.

MelaninsynthesisistriggeredbythehydroxylationofL-phenylalaninetoL-tyrosineordirectlyfromL-tyrosine.TyrosinasehydroxylatesL-tyrosineto3,4-L-dihydroxyphenylalanine(L-DOPA),whichfurtherundergoesoxidationtodopaquinone.Thereafter,twomainpathwaysdiverge,leadingtoproductionofblack-browneumelaninandyellow-redpheomelanin.Melaninsynthesisisregulatedbymultiplecomplexsignalingpathways,includingmelanocyte-stimulatinghormones(MSH)/cAMPandKIT[8].

Geneticmutationsaffectingthepathwaysthatregulatethedifferentiationandmigrationofmelanocyteprecursorsintheneuralcrestortheproliferationandactivityofmaturemelanocytesmaybeinvolvedinthepathogenesisofhyperpigmentationassociatedwithinheritedsyndromes[8].

Hypermelanosis — Skinhyperpigmentationisinmostcasescausedbyincreasedbiosynthesisanddepositionofmelaninintheepidermisand/ordermis.Epidermalhypermelanosisresultsfromanexcessofmelanininthebasalandsuprabasallayersoftheskinduetoincreasedmelaninproductioneitherbyanabnormallyhighnumberofmelanocytesorbyanormalmelanocytepopulation.Theseabnormalitiesmaybeduetobothacquiredandgeneticfactors.

Thenormaldermisdoesnotcontainmelanin.Dermalhypermelanosismaydevelopthroughseveralmechanisms:

●Transferofmelaninfromtheepidermistothedermisandaccumulationwithinmelanophages("pigmentaryincontinence").Thisprocessiscommonlyobservedininflammatoryskindiseasesthatinvolveadamageofthebasallayerand/orthedermoepidermaljunction.

●Productionofmelaninbyectopicdermalmelanocytes.ExamplesofdermalmelanocytosisarethenevusofOtaandnevusofIto.

●Bindingofmelanintoexogenouspigmentsdepositedinthedermis.

Otherpigments — Cutaneoushyperpigmentationcanbecausedbythedepositioninthedermisofendogenousorexogenouspigments,suchashemosiderin,iron,orheavymetals.Recurrentextravasationofredbloodcellsinthedermisleadstodepositionofhemosiderin,resultinginared-browndiscolorationoftheskin.Dermalhyperpigmentationmimickingdermalhypermelanosiscanbecausedbytopicalorsystemicexposuretoheavymetals(eg,silver,gold,mercury).Somemetals,suchasiron,mayalsostimulatemelanogenesis,asobservedinpatientswithhemochromatosis.

PATIENTEVALUATION — Thediagnosisofhyperpigmentationdisordersmaybechallenging.Inmostcases,theinitialpatientevaluationinvolvesadetailedfamilyandpersonalmedicalhistoryandacompletephysicalexamination,whichshouldincludeacarefulsearchforadditionalcutaneousandextracutaneoussignsandsymptoms.

Questionsthatmaybeusefulfortheevaluationofpatientswithhyperpigmentationdisordersinclude[9]:

●Isthedisordercongenitaloracquired?

●Isthedisorderisolatedorpartofasyndrome?

●Isthepigmentationlocalizedordiffuse?

●Isthepigmentationwellcircumscribedorill-defined?

●Doesthepigmentationhaveapattern(eg,linear,reticular)?

●Isthepigmentationassociatedwithinflammationand/orpriorcutaneousinjury?

●Isthepigmentationstable,progressing,orregressing?

●Doesthepatienthaveconcomitantsystemicdiseases?

●Doesthepatienthaveahistoryofexposuretoanewmedication?

History — Adetailedmedicalhistoryshouldbeobtainedfromthepatienttodetermineifthehyperpigmentationisrelatedtoanunderlyingdisease.Thepossibilityofdrug-inducedpigmentationmustbekeptinmind.Patientsshouldalsobequestionedaboutoccupationalandorhobby-relatedexposuretochemicalsthatmaycausehyperpigmentation.

Investigationofthefamilyhistorymaybehelpfultodeterminewhetherthedisorderisacquiredorinherited,and,inthelattercase,whatistheprobableinheritancepattern[10].However,althoughcongenitalorinheritedhyperpigmentationdisordersareoftenpresentatbirth,historymaybemisleading,sinceparentsmaynothavenoteditformonthsorlonger.

Thecourseofthedisorderisalsoausefulparameterintheclinicaldiagnosisofhyperpigmentationdisorders.Inheritedhyperpigmentationsareoftenstable,whereasmostacquiredformsshowprogressionorregression.

Skinexamination — Inallpatientswithhyperpigmentationdisorders,acompleteskinexaminationshouldbeperformedundervisiblelightandWood'slight.Importantclinicalparametersinclude:

●Extentofthepigmentaryabnormality(localizedversusdiffuse)

●Colorhue(shadesofbrown/black,slate-gray/blue)

●Morphologyofindividuallesions

●Distribution(eg,sun-exposedareas,areaspreviouslyinvolvedbyinflammatoryprocesses)

●Pattern(eg,linear,reticular,nonfigurate)

Acarefulsearchforassociatedcutaneousandextracutaneoussignsandsymptomsmayprovideimportantcluestothediagnosis,particularlyinpatientswithhyperpigmentationdisordersassociatedwithsystemicdiseasesorgeneticsyndromes.

Wood'slightexamination — Wood'slight,alsoknownas"blacklight,"isultravioletAlightwithapeakemissionat365nm[11].Thepatientisexaminedinadarkenedroomwiththelightsourceheldat10to15cmfromtheskin.Wood'slightishelpfulindeterminingwhetherthepigmentdepositionispredominantlyepidermal,dermal,ormixed[12].

●Epidermalhypermelanosis–Undernaturallight,epidermalhypermelanosisappearslightbrowntodarkbrownincolor.Thepigmentation,aswellasthecontrastbetweeninvolvedanduninvolvedskin,isenhancedwhenviewedunderaWood'slamp.

●Dermalhypermelanosis–Undernaturallight,dermalhypermelanosishasabluishorashengrayhuewithmarginslessdefinedthanepidermalhypermelanosis.ThepigmentationisnotaccentuatedbytheWood'slight.

●Mixedhypermelanosis–Mixedhypermelanosisappearslighttodarkbrownundernaturallight,whereasWood'slightexaminationwillshowenhancementinsomeareasandnoneinothers.

Reflectanceconfocalmicroscopy — Invivoreflectanceconfocalmicroscopyisatechniquethatallowsnoninvasiveimagingoftheepidermisandpapillarydermisathistologicresolution[13].Theconfocalmicroscopeemitsanear-infraredlightfromadiodelasersourcefocusedonamicroscopicskintarget.Asthislightpenetratescellularstructureswithdifferentrefractionindexes,itisnatural

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 求职职场 > 面试

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1